loading...

Diabetic Foot Ulcer Scale - Short Form (DFS-SF)

Janssen Global Services, LLC (USA); Mapi

Distributed by Mapi Research Trust

ProQolid

Distributed by Mapi Research Trust

Basic description

See also the DFS

Developed in 2003

Authors

Janssen Global Services, LLC (USA); Mapi

Copyright
DFS-SF © 1999 Mapi Research Trust, All rights reserved
Objective
To assess the impact of diabetic foot ulcers and their treatment on patients’ quality of life
Therapeutic area
  • Nutritional and Metabolic Diseases
  • Endocrine System Diseases
  • Skin and Connective Tissue Diseases
Therapeutic indication
  • Diabetes Mellitus
  • Leg Ulcer
Type 1 – IDDM, Type 2 – NIDDM
Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • English for the UK
Bibliographic reference(s) of the original questionnaire

Abetz L, Sutton M, Brady L et al. The Diabetic Foot Ulcer Scale (DFS): a quality of life instrument for use in clinical trials. Practical Diabetes International 2002;19(6):167-175 (Full Text Article)

Bann CM, Fehnel SE, Gagnon DD. Development and validation of the Diabetic Foot Ulcer Scale-short form (DFS-SF). Pharmacoeconomics. 2003;21(17):1277-90 (PubMed Abstract)

Access this questionnaire

Please proceed below

Login SIGN up free

Contact and conditions of use

Authors

Janssen Global Services, LLC (USA); Mapi

Contact information

Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66

Conditions of use

Students, physicians, clinical practice, not-funded academic users

You may access available translations of the questionnaire directly (see tutorial). Should you not see the Download button, please contact us.

Funded academic users, healthcare organizations, commercial users & IT companies

Submit your request (see tutorial). Our PROVIDE team will get back to you with the needed information and license agreement in a timely manner.

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.

Languages

Original language(s)

  • English for the UK

Translations

The listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study. This list is subject to constant changes, therefore please check the status of translations with Mapi Research Trust / the developers / copyright holders / distributors.

DFS-SF

Chinese for Hong Kong
Dutch for Belgium (Flemish)
Dutch for the Netherlands
English for the USA*
French for Canada*
Greek for Greece
Polish for Poland
Portuguese for Brazil
Spanish for the USA*
* Performed by Mapi

The author has selected Mapi/ICON Language Services as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.

For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).

Conditions to translate

Academic Translation

If you wish to translate the questionnaire:

  1. Log in or Register for free
  2. Submit your request for translation online (Tutorials are available on our FAQs)
  3. Our PROVIDE team will send you a translation agreement along with Linguistic Validation Guidelines.

Commercial Users

Exclusive vendor for translation work for commercial users: Mapi/ICON Language Services

E-versions

Conditions to implement in electronic applications

Please refer to the "Contact and conditions of use" tab

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us